Amryt loans from EIB for skin disorder gel aimed for $1.5 billion market
Amryt, the clinical-stage specialty pharmaceutical company focused on fighting rare and orphan diseases, has raised a five-year €20m loan with…
Pharmaceuticals, Biotechnology and Life Sciences
Amryt, the clinical-stage specialty pharmaceutical company focused on fighting rare and orphan diseases, has raised a five-year €20m loan with…
Bristol-Myers gets exclusive worldwide rights to develop Nitto’s investigational anti-fibrosis drug
The European Patent Office has issued a patent covering the Akers Biosciences’ Breath Ketone Detector, a single-use, non-invasive, breath device…
Probiodrug AG (Euronext Amsterdam: PBD), a biopharmaceutical company developing therapeutic solutions to treat Alzheimer’s disease, has finished the third quarter 2016…
GENFIT has signed an agreement for a NASH Registry Project
Horizon Discovery Group has entered into an Original Equipment Manufacturer (OEM) agreement with CareDx…
Dechra has appointed Lawson Macartney to the Board
Oxford Pharma’s OXPzero Ibuprofen going back into the clinic
Valneva has reported financial results for first nine months of 2016.
Nicox S.A., the international ophthalmic R&D company, has provided an update on the regulatory status of its key projects, latanoprostene bunod and AC-170.